Cite
Determination of plasma concentration of Belimumab by LC-MS/MS: Method development, validation, and clinical application.
MLA
Marin, Clémence, et al. “Determination of Plasma Concentration of Belimumab by LC-MS/MS: Method Development, Validation, and Clinical Application.” Journal of Pharmaceutical and Biomedical Analysis, vol. 236, Nov. 2023, p. 115730. EBSCOhost, https://doi.org/10.1016/j.jpba.2023.115730.
APA
Marin, C., Noé, G., Schlemmer, D., Beaulieu, Q., Robidou, P., Mansour, B., Hirtz, C., Vialaret, J., Antignac, M., Moyon, Q., Benameur, N., Amoura, Z., & Zahr, N. (2023). Determination of plasma concentration of Belimumab by LC-MS/MS: Method development, validation, and clinical application. Journal of Pharmaceutical and Biomedical Analysis, 236, 115730. https://doi.org/10.1016/j.jpba.2023.115730
Chicago
Marin, Clémence, Gaëlle Noé, Dimitri Schlemmer, Quentin Beaulieu, Pascal Robidou, Bochra Mansour, Christophe Hirtz, et al. 2023. “Determination of Plasma Concentration of Belimumab by LC-MS/MS: Method Development, Validation, and Clinical Application.” Journal of Pharmaceutical and Biomedical Analysis 236 (November): 115730. doi:10.1016/j.jpba.2023.115730.